Literature DB >> 31229882

Inflammasomes and Leishmania: in good times or bad, in sickness or in health.

Dario S Zamboni1, David L Sacks2.   

Abstract

The inflammasomes are multi-molecular platforms that are activated in host cell cytoplasm when the innate immune cells are infected with pathogens or exposed to damage signals. Many independent groups reported that Leishmania infection trigger activation of the NLRP3 inflammasome in macrophages for restriction of intracellular parasite replication. Accordingly, Leishmania can dampen NLRP3 activation as an evasion strategy. In vivo, the NLRP3 inflammasome can promote parasite clearance, but the failure to eliminate parasites in the tissues together with sustained inflammasome activation can promote IL-1β-mediated disease pathology. In this review, we discuss the recent data regarding activation of the NLRP3 inflammasome in response to Leishmania and the beneficial and detrimental effects of the inflammasome during development of Leishmaniasis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31229882      PMCID: PMC6910972          DOI: 10.1016/j.mib.2019.05.005

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  35 in total

1.  Gut Microbes Egested during Bites of Infected Sand Flies Augment Severity of Leishmaniasis via Inflammasome-Derived IL-1β.

Authors:  Ranadhir Dey; Amritanshu B Joshi; Fabiano Oliveira; Lais Pereira; Anderson B Guimarães-Costa; Tiago D Serafim; Waldionê de Castro; Iliano V Coutinho-Abreu; Parna Bhattacharya; Shannon Townsend; Hamide Aslan; Alec Perkins; Subir Karmakar; Nevien Ismail; Morgan Karetnick; Claudio Meneses; Robert Duncan; Hira L Nakhasi; Jesus G Valenzuela; Shaden Kamhawi
Journal:  Cell Host Microbe       Date:  2017-12-28       Impact factor: 21.023

2.  The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control.

Authors:  Vanessa Ribeiro Figliuolo; Suzana Passos Chaves; Luiz Eduardo Baggio Savio; Maria Luiza Prates Thorstenberg; Érika Machado Salles; Christina Maeda Takiya; Maria Regina D'Império-Lima; Herbert Leonel de Matos Guedes; Bartira Rossi-Bergmann; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2016-11-19       Impact factor: 3.765

3.  Macrophage priming is dispensable for NLRP3 inflammasome activation and restriction of Leishmania amazonensis replication.

Authors:  Renan V H de Carvalho; Alexandre L N Silva; Leonardo L Santos; Warrison A Andrade; Keyla S G de Sá; Dario S Zamboni
Journal:  J Leukoc Biol       Date:  2019-05-07       Impact factor: 4.962

4.  IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity.

Authors:  Yoichiro Ohne; Jonathan S Silver; LuAnn Thompson-Snipes; Magalie A Collet; Jean Philippe Blanck; Brandi L Cantarel; Alan M Copenhaver; Alison A Humbles; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

5.  Caspase-11 gene expression in response to lipopolysaccharide and interferon-gamma requires nuclear factor-kappa B and signal transducer and activator of transcription (STAT) 1.

Authors:  Reinout Schauvliege; Jill Vanrobaeys; Peter Schotte; Rudi Beyaert
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

6.  Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response.

Authors:  Flavia L Ribeiro-Gomes; Nathan C Peters; Alain Debrabant; David L Sacks
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

7.  PKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection.

Authors:  Marina Tiemi Shio; Jan Gregor Christian; Jee Yong Jung; Kwang-Poo Chang; Martin Olivier
Journal:  PLoS Negl Trop Dis       Date:  2015-06-26

8.  Kaurenoic Acid Possesses Leishmanicidal Activity by Triggering a NLRP12/IL-1β/cNOS/NO Pathway.

Authors:  Milena Menegazzo Miranda; Carolina Panis; Suelen Santos da Silva; Juliana Aparecida Macri; Natalia Yoshie Kawakami; Thiago Hideki Hayashida; Tiago Bervelieri Madeira; Vinicius Ricardo Acquaro; Suzana Lucy Nixdorf; Luciana Pizzatti; Sérgio Ricardo Ambrósio; Rubens Cecchini; Nilton Syogo Arakawa; Waldiceu Aparecido Verri; Ivete Conchon Costa; Wander Rogério Pavanelli
Journal:  Mediators Inflamm       Date:  2015-05-13       Impact factor: 4.711

9.  Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology.

Authors:  Fernanda O Novais; Lucas P Carvalho; Sara Passos; David S Roos; Edgar M Carvalho; Phillip Scott; Daniel P Beiting
Journal:  J Invest Dermatol       Date:  2014-07-18       Impact factor: 8.551

10.  An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis.

Authors:  Prajwal Gurung; Rajendra Karki; Peter Vogel; Makiko Watanabe; Mark Bix; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808

View more
  11 in total

Review 1.  Epigenetic paradigms/exemplars of the macrophage: inflammasome axis in Leishmaniasis.

Authors:  Manei M Aljedaie
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

2.  A Mouse Model of Ulcerative Cutaneous Leishmaniasis by Leishmania (Viannia) panamensis to Investigate Infection, Pathogenesis, Immunity, and Therapeutics.

Authors:  Natalia Muñoz-Durango; Alexander Gómez; Natalia García-Valencia; Miguel Roldán; Marcela Ochoa; David E Bautista-Erazo; José R Ramírez-Pineda
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

Review 3.  Protective or Detrimental? Understanding the Role of Host Immunity in Leishmaniasis.

Authors:  Camila Dos Santos Meira; Lashitew Gedamu
Journal:  Microorganisms       Date:  2019-12-13

4.  P2Y2 Receptor Induces L. amazonensis Infection Control in a Mechanism Dependent on Caspase-1 Activation and IL-1β Secretion.

Authors:  Maria Luiza Thorstenberg; Monique Daiane Andrade Martins; Vanessa Figliuolo; Claudia Lucia Martins Silva; Luiz Eduardo Baggio Savio; Robson Coutinho-Silva
Journal:  Mediators Inflamm       Date:  2020-10-01       Impact factor: 4.711

5.  Endosymbiotic RNA virus inhibits Leishmania-induced caspase-11 activation.

Authors:  Renan V H de Carvalho; Djalma S Lima-Júnior; Caroline V de Oliveira; Dario S Zamboni
Journal:  iScience       Date:  2020-12-29

6.  Insight Into Inflammasome Signaling: Implications for Toxoplasma gondii Infection.

Authors:  Yang Wang; Jinjin Zhu; Yuanyuan Cao; Jilong Shen; Li Yu
Journal:  Front Immunol       Date:  2020-12-16       Impact factor: 7.561

7.  Dissection of the macrophage response towards infection by the Leishmania-viral endosymbiont duo and dynamics of the type I interferon response.

Authors:  Amel Bekkar; Nathalie Isorce; Tiia Snäkä; Stéphanie Claudinot; Chantal Desponds; Dmitry Kopelyanskiy; Florence Prével; Marta Reverte; Ioannis Xenarios; Nicolas Fasel; Filipa Teixeira
Journal:  Front Cell Infect Microbiol       Date:  2022-08-04       Impact factor: 6.073

8.  Eimeria falciformis secretes extracellular vesicles to modulate proinflammatory response during interaction with mouse intestinal epithelial cells.

Authors:  Joshua Seun Olajide; Ling Xiong; Shunli Yang; Zigang Qu; Xiao Xu; Bin Yang; Jing Wang; Baohong Liu; Xueting Ma; Jianping Cai
Journal:  Parasit Vectors       Date:  2022-07-08       Impact factor: 4.047

9.  Involvement of the Inflammasome and Th17 Cells in Skin Lesions of Human Cutaneous Leishmaniasis Caused by Leishmania (Viannia) panamensis.

Authors:  K Gonzalez; J E Calzada; C E P Corbett; A Saldaña; M D Laurenti
Journal:  Mediators Inflamm       Date:  2020-10-27       Impact factor: 4.711

Review 10.  Purinergic signaling: A new front-line determinant of resistance and susceptibility in leishmaniasis.

Authors:  Mariana Chaves; Luiz Eduardo Savio; Robson Coutinho-Silva
Journal:  Biomed J       Date:  2021-06-24       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.